Good morning everyone, lets get these 0003's bought up today.Feeling pretty good about the press release,i see the bashers crawled back in there holes.When this becomes official it will be a great day for us longs.So it looks like the next pr will be the one we have been waiting for no fluff.Everyone sitting on the sideline needs to get in now before we run,not to much more the bashers can do to pull the stock down so i would take the 0003's & spend a couple hundred bucks,If you are in pinky land like we are,its not going to get any better than this,what pinky company is doing business with a real legit company,what pinky company is calling and emailing shareholders back,& what pinky company has a 2billion dollar project lined up with almost no other competition, NONE, enough said.
Good morning everyone, lets get these 0003's bought up
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
OnTime's Bold Vision: Transforming Home Healthcare Admin
Changing the Game for Home Healthcare Every now and then, an idea rolls in that speaks to a real need, and OnTime's push to soften the burdens of the home healthcare industry might just be one of those. Built from grassroots experience, they're dropping efforts to modernize the back-end monotony so healthcare workers can zero in on, well, healthcare. A Nose-Dive into...
Continue Reading
Image Analysis Group Unveils DYNAMIKA V.7 for Clinical Trials
Introduction to DYNAMIKA V.7 by Image Analysis Group Image Analysis Group (IAG) has recently launched DYNAMIKA V.7, an advanced cloud platform tailored for clinical trial imaging. Following stringent audits and certifications, including SOC II Type I compliance and British Standards Institute (BSI) surveillance audit certification, this platform stands out in its field....
Continue Reading
Sanofi's Strategic Move to Enhance Adult Vaccination Pipeline
Sanofi Strengthens Its Vaccination Portfolio Sanofi SA (NASDAQ: SNY) has made a significant step in the healthcare sector by acquiring Dynavax Technologies Corporation (NASDAQ: DVAX) for approximately $2.2 billion. This acquisition, which involves a cash purchase price of $15.50 per share, signals Sanofi's commitment to enhancing its capabilities in the adult immunization...
Continue Reading
Miral Impact Fund: A New Era for Community and Environment
Introducing the Miral Impact Fund Miral has taken a significant step towards environmental stewardship and social responsibility by launching the Miral Impact Fund. This initiative, launched in partnership with the Authority of Social Contribution – Ma'an, aims to create a positive impact within communities by addressing pressing social issues while promoting...
Continue Reading
Class Action Update for Regeneron Pharmaceuticals Investors
Class Action Lawsuit Overview for Regeneron Pharmaceuticals Levi & Korsinsky, LLP has announced that Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) investors should take note of a pending class action lawsuit concerning alleged securities fraud. Understanding the Class Action The lawsuit aims to recover losses for investors adversely affected by claims of fraud that...
Continue Reading